Dr. Sitanshu Sekhar Kar
MBBS, MD, MBA Hospital Management
2012- 2014: FAIMER Fellowship, PSG FAIMER Regional Institute, Coimbatore, Tamil Nadu, India
2016- 2017: Graduate Certificate Program on Tobacco Control. Institute for Global Tobacco Control. Johns Hopkins University, The Bloomberg School of Public Health, Maryland, US
2016- 2017: Fulbright-Nehru Academic Professional Excellence Fellow (FN-APE) at USC Institute for Global Health, Los Angeles, California, USA
2018- 2019: Scholars’ Leadership program on Tobacco Control (2018-2019). Institute for Global Tobacco Control. Johns Hopkins University, Bloomberg School of Public Health, Maryland, US
Journals: 160
Book 1 and Selected book chapters/ Reports/ Guidelines (25)
Research Gate:
https://www.researchgate.net/profile/Sitanshu_Kar/research
ORCiD: https://orcid.org/0000-0001-7122-523X
Scopus h-index (12) https://www.scopus.com/authid/detail.uri?authorId=36018156200
1. Goel S, Kar SS, Verma M, Sivanantham P, Naik BN, Gupta D. Evidence on article 5.3 of FCTC (tobacco industry interference in tobacco control activities) in India-a qualitative scoping study. BMC public health. 2021;21(1):1–17.
2. Jyani G, Sharma A, Prinja S, Kar SS, Trivedi M, Patro BK, et al. Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set. Value in Health. 2022; DOI:https://doi.org/10.1016/j.jval.2021.11.1370
3. Sivanantham P, Sahoo J, Lakshminarayanan S, Bobby Z, Kar SS (2021) Profile of risk factors for Non-Communicable Diseases (NCDs) in a highly urbanized district of India: Findings from Puducherry district-wide STEPS Survey, 2019–20. PLoS ONE 16(1): e0245254. https://doi.org/10.1371/journal. pone.0245254
4. Lohiya A, Daniel RA, Kar SS, Sahu SK, Nongkynrih B, Varghese C. Measuring outcomes of hypertension treatment in primary care in resource-limited settings. WHO South East Asia J Public Health 2019;8(2):112–4.
5. Krishnamoorthy Y, Rajaa S, Murali S, Rehman T, Sahoo J, Kar SS. Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis. PLoS One 2020;15(10):e0240971.
6. Neogi SB, Sharma J, Pandey S, Zaidi N, Bhattacharya M, Kar R, Kar SS, et al. Diagnostic accuracy of point-of-care devices for detection of anemia in community settings in India. BMC Health Serv Res 2020;20(1):468.
7. Parameswaran S, Rinu PK, Kar SS, Harichandrakumar KT, James TD, Priyamvada PSP, et al. A Newly Recognized Endemic Region of CKD of Undetermined Etiology (CKDu) in South India-"Tondaimandalam Nephropathy". Kidney Int Rep 2020;5(11):2066–73.
8. Jyani G, Prinja S, Kar SS, Trivedi M, Patro B, Purba F, et al. Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study. BMJ Open 2020;10(11):e039517.
9. Kar S, Sarkar S, Murali S, Dhodapkar R, Joseph N, Aggarwal R. Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August–October 2020. Emerg Infect Dis. 2021;27(2):666-669. https://dx.doi.org/10.3201/eid2702.204480
10. Guru PK, Kar SS. Renal failure deaths and their risk factors in India 2001-13. Lancet Glob Health 2017;5(5):e482.
Research Projects as Principal Investigator
| No | Title, sanction number & date | Source of funding | From | To | Amount (INR) |
|---|---|---|---|---|---|
| A. Extramural | |||||
| 1. | Scoping study to document evidence on Article 5.3 of Framework Convention on Tobacco Control (FCTC) in India (Phase I & II) | The Union, SEA, New Delhi | 2017 | 2018 | 1,62,000 1,92,000 |
| 2. | Advancing tobacco control at national and sub-national level through capacity building, MPOWER implementation and support to National Tobacco Control Programme (NTCP) | PGIMER & The Union, New Delhi | 2018 | 2022 | Phase I 6,02,030 Phase II 5,87,230 |
| 3. | Making Puducherry a tobacco-free Union Territory (Scholars’ program fellowship) | IGTC, JHSPH, US | 2018 | 2020 | 7,82,372 ($11,450) |
| 4. | Development of health-related quality of life (EQ-5D-5L) value set for India | DHR, India | 2019 | 2020 | 7,91,250 |
| 5. | Establishment of Health Technology Assessment Resource center in JIPMER | DHR, India | 2019 | 2022 | 48,75,970 |
| 6. | Identification of factors contributing to out-of- pocket expenditure on medicines in India | NHSRC, India | 2020 | 2020 | 6,15,700 |
| 7. | Seroprevalence survey of SARS-CoV-2 infection in Puducherry district | JIPMER (Intramural) | 2020 | 2021 | 15,00,000 |
| B. Intramural | |||||
| 8. | Risk factors survey for non-communicable diseases using WHO steps approach in Puducherry district – South India | Ph.D. | 2017 | 2020 | 3,50,000 |
| 9. | Health risk assessment among nursing staff of a tertiary care hospital in Puducherry district South-India | Ph.D. | 2017 | 2020 | 5,25,000 |
Awards & Recognitions:
- Awarded Best Research Paper at the 1st World NCD Congress Organized by World NCD Forum at PGIMER, Chandigarh from 3rd to 7th Nov 2017.
- Awarded Best Paper in the Non-communicable disease session at the 60th National Annual Conference of IPHA organized by Himalayan Institute of Medical Sciences, Dehradun, 4th to 6th March 2016.
- Successfully completed the Training Programme for Young Leaders in Health Administration Course at the University of Miyazaki from 1st December 2013 to 13th December 2013 organized by the Japan International Cooperation Agency (JICA) under the International Cooperation Programme of the Government of Japan.
- Was awarded the Best Research Paper in young scientist category (Kalu Ram Memorial Award) for the best community based research in 40th National IAPSM conference, Nagpur from 22nd to 24th Jan 2013.
- Awarded ‘Silver Medal’ of merit i.e., Merit of first order, in M.D. examination in PGIMER, Chandigarh. April 2006.
- Second prize in poster presentation competition held at 8th South East Asia Regional Scientific Meeting of International Epidemiological Association held at Jhansi, Dec 2004.
- Sanatan Pujari Gold Medal for securing first position in Anatomy in 1st MBBS (April 1997). Secured Honours (> 75% mark in the subject) in Anatomy and Physiology in 1st MBBS (April, 1997) and Honours in Pathology (> 75% mark in the subject) in 2nd MBBS. (April 1999).
| No. | Position / responsibility | Specific contribution |
|---|---|---|
| 1 | Associate Dean Research 2016-2020 | 1. Initiated longitudinal PhD capacity building programme 2. Proposed celebration of Research Day in JIPMER to promote research culture (assisted in organizing first four Research Day celebration in JIPMER) 3. Assisted in organization of first three Connaissance – International UG Conference 4. Was involved in curriculum planning for Ph.D. programme 5. Managed and sorted out the issues pertaining to roll out of research management SFACT software |
| 2 | JIPMER International School of Public Health Monitoring Committee (Mem Secy) 2015-2019 | 1. Actively involved in planning, conceptualization, drafting detailed project report for JISPH 2. Instrumental in starting the MPH course in JISPH (planning, implementation and execution for last 7 years) |
| 3 | JIPMER Research Advisory Council 2016-2018 | 1. The scope of work included advice JIPMER administration on matters of research policy and strategy. 2. Promote collaborative research. 3. Develop SoPs/ guidelines for infrastructure development, capacity development and resource mobilization |
| 4 | Ph.D. Research Monitoring committee 2017-2020 | 1. Actively participated monitoring of all PhDRMC activities 2. Monitoring the progress of research work by Ph.D. candidate as Ph.D. RMC nominee. |
| 5 | Member of JIPMER Scientific Advisory Committee 2015-2018 | 1. Reviewed the faculty, PG, PhD proposals as a member of the JSAC. |
| 6 | NTTC Core group faculty 2012 - onwards | 1. Part of NTTC core group faculty and take part in around 10 faculty Development programme (FDP) every year to build capacity of MEU members of affiliated colleges. 2. Actively involved in revising the MBBS curriculum to Systems based integrated curriculum from traditional curriculum. 3. Actively involved in revision of syllabus for the subject Community Medicine |
| 7 | JIPMER COVID Taskforce 2020-2021 | 1. Responsible for presenting the trend, coordination with UT administration, projection of the pandemic 2. Manging the Containment zone within JIPMER campus 3. Provided technical support to the UT COVID group for policy making 4. Tracking of MoHFW guidelines and development of SoPs for contact tracing, interstate travel and home isolation issues. |
| 8 | JIPMER COVID-19 vaccination drive 2020-21 | 1. Responsible for planning and implementation of Vaccination center at JIPMER, Puducherry |